Insiders Antibe Therapeutics Inc.

Equities

ATE

CA0370255097

Delayed Toronto S.E. Other stock markets 11:00:00 2024-04-16 am EDT			5-day change	1st Jan Change
0.295 ^CAD	0.00%		0.00%	-68.28%

Apr. 24	Antibe Therapeutics Inc. Announces Board Resignations	CI
Apr. 19	Antibe Therapeutics Seeks Extension of Stay of Proceedings	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Antibe Therapeutics Inc. Announces Board Resignations	Apr. 24	CI
Antibe Therapeutics Inc. Announces Board Resignations	Apr. 09	CI
Antibe Therapeutics Inc. Announces Formation of Executive Committee	Apr. 01	CI
Antibe Therapeutics Inc. Announces Retirement of Dr. John L. Wallace from the Board of Directors	23-02-15	CI
Antibe Therapeutics Names New Board Chair, Corporate Vice Chairs	22-05-25	MT
Antibe Therapeutics Appoints New Board Chair and Corporate Vice Chairs	22-05-25	CI
Antibe Therapeutics Inc. Appoints Don Haut to Its Partnering Advisory Team	21-01-07	CI
Antibe Therapeutics Inc. Announces Board Appointments	20-11-24	CI
Antibe Therapeutics Inc. Announces Hiring of Joseph Stauffer as Chief Medical Officer	20-05-06	CI
Antibe Therapeutics Inc. Announces Management Changes	20-01-13	CI
Antibe Therapeutics Establishes Business Development Advisory Board	18-10-22	CI
Antibe Therapeutics Inc. Appoints Amal Khouri to its Board of Directors	18-03-20	CI
Antibe Therapeutics Inc. Appoints Yung Wu to its Board of Directors	16-07-19	CI
Antibe Therapeutics Inc. Appoints Alain Wilson to Position of Chief Financial Officer	15-12-01	CI
Antibe Therapeutics Inc. Announces Resignation of Jonathan Ross Goodman from Board of Directors	15-02-27	CI
Antibe Therapeutics Announces Appointment of J. Carter Thorne to its Clinical Advisory Board	14-12-18	CI
Antibe Therapeutics Inc. Announces the Formation of its Clinical Advisory Board	14-07-17	CI
Antibe Therapeutics Inc. Appoints Jeremy Grushcow to the Part-Time Role of VP Legal and Strategy	13-10-22	CI
Antibe Therapeutics Inc. Approves Board Nominees	13-10-04	CI
Antibe Therapeutics Inc. Announces Board Changes	13-08-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Antibe Therapeutics Inc.

Equities

ATE

CA0370255097

Insiders

Filters